Financials
- Market Capitalization 723.71 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2643 | CLYM Climb Bio, Inc. - Common Stock | 13.24 USD | +0.23% | +0.76% | +15.03% | +142.05% | 758.13 M USD | ||
| 2646 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.61 USD | -1.68% | +0.13% | -22.35% | -17.37% | 755.70 M USD | ||
| 2679 | CADL Candel Therapeutics, Inc. - Common Stock | 9.87 USD | +2.39% | +2.49% | +16.39% | +55.92% | 723.18 M USD | ||
| 2692 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.82 USD | +3.52% | +1.73% | +13.51% | -7.06% | 706.54 M USD |
Frequently asked questions about Aura Biosciences, Inc. - Common Stock
What is the Aura Biosciences, Inc. - Common Stock stock price today?
The current price of Aura Biosciences, Inc. - Common Stock (AURA) is 7. Over the past 24 hours, the stock has changed by 0.00%. Follow the AURA chart for real-time price dynamics.
What is the stock ticker of Aura Biosciences, Inc. - Common Stock?
Aura Biosciences, Inc. - Common Stock trades under the ticker AURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aura Biosciences, Inc. - Common Stock stock going up?
AURA has changed by -0.43% over the last week, +9.03% over the last month, and +6.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Aura Biosciences, Inc. - Common Stock net income for the last quarter?
Aura Biosciences, Inc. - Common Stock reported net income of -33.69 M for the last quarter. The previous quarter showed -25.56 M, which means net income changed by -31.79%.
How many employees does Aura Biosciences, Inc. - Common Stock have?
As of the latest available data, Aura Biosciences, Inc. - Common Stock has 113 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aura Biosciences, Inc. - Common Stock EBITDA?
Aura Biosciences, Inc. - Common Stock EBITDA is -40.31 M, and its EBITDA margin is -3 387.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aura Biosciences, Inc. - Common Stock stock?
You can buy Aura Biosciences, Inc. - Common Stock (AURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aura Biosciences, Inc. - Common Stock stock?
Investing in Aura Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AURA chart and related analysis on metatrader.com as part of your research.